Drop the pounds and the sugar with new guidelines New rules to manage diabetes means using new tools. Leverage GLP-1 RA and SGLT2-i to drop with pounds and the sugars with the expert insight from our guest, Dr. Marie McDonnell. Claim free CME for this episode at curbsiders.vcuhealth.org Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments Puns and Intro. Disclaimer and Guest bio Case from Kashlak Labs to distinguish type 1 from type 2 diabetes Selecting initial therapy: Focus on weight loss and glucose control HbA1c goals  Yeast infections and SGLT2-i Using sulfonylureas and extended release metformin Pancreatitis and GLP-1 RA Cancer and GLP-1 RA Semaglutide tips Tirzepatide, how it works and benefits Take home points Outro Credits Producer: Matthew Watto, MD and Isabel Valdez, PA Writer: Matthew Watto, MD Show Notes, Cover Art and Infographics: Isabel Valdez, PA Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Fatima Syed, MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest:  Marie E. McDonnell, MD Sponsor: Locumstory Get a comprehensive view of locums at locumstory.com Full transcript available HERE 

Dr. Marie McDonnell, a leading expert in diabetes advancements, discusses the evolving landscape of diabetes care. The conversation covers the personalized approach to managing type 2 diabetes, emphasizing real-life strategies over numerical guidelines. New medications like GLP-1 agonists are highlighted for their effectiveness, along with the importance of lifestyle changes. The role of extended-release medications and optimizing metformin dosing for patient adherence are also explored, showcasing innovative strategies for better diabetes management.